Research ArticleArticle
Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis
Lisa K. Stamp, Murray L. Barclay, John L. O’Donnell, Mei Zhang, Jill Drake, Christopher Frampton and Peter T. Chapman
The Journal of Rheumatology October 2011, jrheum.110481; DOI: https://doi.org/10.3899/jrheum.110481
Lisa K. Stamp
Murray L. Barclay
John L. O’Donnell
Mei Zhang
Jill Drake
Christopher Frampton
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis
Lisa K. Stamp, Murray L. Barclay, John L. O’Donnell, Mei Zhang, Jill Drake, Christopher Frampton, Peter T. Chapman
The Journal of Rheumatology Oct 2011, jrheum.110481; DOI: 10.3899/jrheum.110481
Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis
Lisa K. Stamp, Murray L. Barclay, John L. O’Donnell, Mei Zhang, Jill Drake, Christopher Frampton, Peter T. Chapman
The Journal of Rheumatology Oct 2011, jrheum.110481; DOI: 10.3899/jrheum.110481